Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Karyopharm Therapeutics (KPTI) Long-Term Debt Issuances (2025)

Historic Long-Term Debt Issuances for Karyopharm Therapeutics (KPTI) over the last 3 years, with Q4 2025 value amounting to $15.0 million.

  • Karyopharm Therapeutics' Long-Term Debt Issuances changed N/A to $15.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $15.0 million, marking a year-over-year change of. This contributed to the annual value of $15.0 million for FY2025, which is 8199.28% down from last year.
  • As of Q4 2025, Karyopharm Therapeutics' Long-Term Debt Issuances stood at $15.0 million.
  • In the past 5 years, Karyopharm Therapeutics' Long-Term Debt Issuances ranged from a high of $15.0 million in Q4 2025 and a low of $15.0 million during Q4 2025